COSCIENS Biopharma Inc. (TSX:CSCI)

COSCIENS Biopharma Statistics

Total Valuation

TSX:CSCI has a market cap or net worth of CAD 14.82 million. The enterprise value is -1.75 million.

Market Cap	14.82M
Enterprise Value	-1.75M

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

TSX:CSCI has 3.15 million shares outstanding. The number of shares has increased by 57.27% in one year.

Current Share Class	3.15M
Shares Outstanding	3.15M
Shares Change (YoY)	+57.27%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	0.56%
Owned by Institutions (%)	0.86%
Float	2.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.14
PB Ratio	1.02
P/TBV Ratio	1.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	0.07
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.08

Financial Position

The company has a current ratio of 2.88, with a Debt / Equity ratio of 0.22.

Current Ratio	2.88
Quick Ratio	2.21
Debt / Equity	0.22
Debt / EBITDA	n/a
Debt / FCF	-0.15
Interest Coverage	-86.36

Financial Efficiency

Return on equity (ROE) is -151.97% and return on invested capital (ROIC) is -57.41%.

Return on Equity (ROE)	-151.97%
Return on Assets (ROA)	-23.33%
Return on Invested Capital (ROIC)	-57.41%
Return on Capital Employed (ROCE)	-48.77%
Revenue Per Employee	324,482
Profits Per Employee	-631,104
Employee Count	40
Asset Turnover	0.29
Inventory Turnover	3.78

Taxes

In the past 12 months, TSX:CSCI has paid 712,926 in taxes.

Income Tax	712,926
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -45.31% in the last 52 weeks. The beta is 1.77, so TSX:CSCI's price volatility has been higher than the market average.

Beta (5Y)	1.77
52-Week Price Change	-45.31%
50-Day Moving Average	4.84
200-Day Moving Average	4.48
Relative Strength Index (RSI)	48.30
Average Volume (20 Days)	1,449

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSX:CSCI had revenue of CAD 12.98 million and -25.24 million in losses. Loss per share was -8.69.

Revenue	12.98M
Gross Profit	6.13M
Operating Income	-16.88M
Pretax Income	-24.53M
Net Income	-25.24M
EBITDA	-15.11M
EBIT	-16.88M
Loss Per Share	-8.69

Balance Sheet

The company has 19.78 million in cash and 3.20 million in debt, giving a net cash position of 16.58 million or 5.27 per share.

Cash & Cash Equivalents	19.78M
Total Debt	3.20M
Net Cash	16.58M
Net Cash Per Share	5.27
Equity (Book Value)	14.58M
Book Value Per Share	4.63
Working Capital	19.11M

Cash Flow

In the last 12 months, operating cash flow was -20.22 million and capital expenditures -1.74 million, giving a free cash flow of -21.96 million.

Operating Cash Flow	-20.22M
Capital Expenditures	-1.74M
Free Cash Flow	-21.96M
FCF Per Share	-6.98

Margins

Gross margin is 47.26%, with operating and profit margins of -130.07% and -194.50%.

Gross Margin	47.26%
Operating Margin	-130.07%
Pretax Margin	-189.00%
Profit Margin	-194.50%
EBITDA Margin	-116.45%
EBIT Margin	-130.07%
FCF Margin	n/a

Dividends & Yields

TSX:CSCI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-57.27%
Shareholder Yield	n/a
Earnings Yield	-170.31%
FCF Yield	-148.17%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 3, 2024. It was a reverse split with a ratio of 0.25.

Last Split Date	May 3, 2024
Split Type	Reverse
Split Ratio	0.25

Scores

TSX:CSCI has an Altman Z-Score of -0.78 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.78
Piotroski F-Score	3